Physician profile
Scott E Rand
NPI 1316946452
$1,202.62
in general payments reported to CMS, 2019-2025
12 companies · $51.32 in 2025
The $51.32 reported for 2025 was less than what a typical Sports Medicine (Family Medicine) provider received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $192 · 2021: $109 · 2022: $149 · 2023: $168 · 2024: $46.25 · 2025: $51.32.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $266.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $388.23 | 2019-2021 | |
| Horizon Therapeutics Plc | $359.86 | 2019-2022 | |
| Kowa Pharmaceuticals America, INC. | $118.98 | 2023 | Seglentis |
| Ferring Pharmaceuticals INC. | $103.93 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $72.03 | 2023-2025 | Iovera, Zilretta, Exparel |
| Depuy Synthes Sales INC. | $31.51 | 2021-2025 | Orthovisc, Monovisc |
| Becton, Dickinson and Company | $29.63 | 2024 | Arista Ah Flexitip |
| Abbott Laboratories | $29.46 | 2023-2025 | Proclaim |
| Bioventus LLC | $25.15 | 2019-2020 | |
| Ucb, INC. | $18.40 | 2019 | |
| Si-Bone, INC. | $12.95 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Rand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.